IMMUNEERING CORP - CLASS A (IMRX) Stock Analyst Ratings
USA - NASDAQ:IMRX - US45254E1073 - Common Stock
6.91 USD
+0.02 (+0.29%)
6.75 USD
-0.16 (-2.32%)
ChartMill assigns a Buy % Consensus number of 84% to IMRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 16.93. This target is 145.04% above the current price.
IMRX was analyzed by 11 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about IMRX.
In the previous month the buy percentage consensus was at a similar level.
IMRX was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-31 | Leerink Partners | Initiate | Outperform |
| 2025-09-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-26 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-09-25 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-09-15 | Needham | Maintains | Buy -> Buy |
| 2025-08-26 | Needham | Reiterate | Buy -> Buy |
| 2025-08-14 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-06-18 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-06-18 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-06-18 | Needham | Reiterate | Buy -> Buy |
| 2025-06-05 | Needham | Reiterate | Buy -> Buy |
| 2025-05-07 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-05-06 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-04-10 | Needham | Reiterate | Buy -> Buy |
| 2025-03-24 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-03-21 | Needham | Reiterate | Buy -> Buy |
| 2025-02-06 | Needham | Reiterate | Buy -> Buy |
| 2025-01-13 | Needham | Reiterate | Buy -> Buy |
| 2025-01-08 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-01-07 | Needham | Reiterate | Buy -> Buy |
| 2024-11-20 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-11-14 | Needham | Reiterate | Buy -> Buy |
| 2024-09-13 | Needham | Reiterate | Buy -> Buy |
| 2024-08-07 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-08-07 | Needham | Reiterate | Buy -> Buy |
| 2024-05-08 | Needham | Reiterate | Buy -> Buy |
| 2024-04-12 | Needham | Reiterate | Buy -> Buy |
| 2024-04-02 | Mizuho | Maintains | Buy -> Buy |
| 2024-03-15 | TD Cowen | Downgrade | Outperform -> Market Perform |
| 2024-03-15 | Chardan Capital | Maintains | Buy -> Buy |
IMMUNEERING CORP - CLASS A / IMRX FAQ
What is the price target for IMRX stock?
11 analysts have analysed IMRX and the average price target is 16.93 USD. This implies a price increase of 145.04% is expected in the next year compared to the current price of 6.91.
How do analysts rate IMMUNEERING CORP - CLASS A (IMRX)?
The consensus rating for IMMUNEERING CORP - CLASS A (IMRX) is 83.6364 / 100 . This indicates that analysts generally have a positive outlook on the stock.